Who we are

Our team

The NGOs delegation to the UNITAID Board works with a broad constituency of NGOs to effectively represent their views, voices, needs and interests at the UNITAID Board and Committee level, and to report back to the constituency on their activities. The delegation also works to raise awareness and increase debate about UNITAID work areas amongst global civil society, fostering engagement on UNITAID from country to global level, and striving to be transparent and accountable Board delegates.

The NGO delegation collaborates closely with the UNITAID board delegation representing Communities affected by HIV/AIDS, TB and malaria, aiming to further advance priorities as identified by Communities.

The NGO delegation is made up of a group of 250 NGOs and is led by the UNITAID NGO Board Member, Fifa Rahman and UNITAID NGO Alternate Board Member, Rohit Malpani.

What we work on

The NGO and Communities delegations work with the UNITAID Secretariat to support the development of civil society engagement within UNITAID. Civil Society should be integrated into UNITAID’s core areas of work including:

 

  • UNITAID’s strategy and upstream policy and priorities: UNITAID has developed a strategy for 2017-2021 and we have worked to make sure civil society is meaningfully involved and that opportunities for civil society engagement are built into UNITAID’s disease narratives and proposed areas for intervention as they are developed.
  • Demand Creation within UNITAID projects: Developing and marketing better, safer, and simpler medicines and diagnostics for use does not guarantee that these tools will be available and used. CS has proven that obstacles between product development and uptake can be overcome through targeted advocacy to create demand. Example of demand creation could include: treatment literacy, preparing healthy systems for new products, campaigns to accelerate adoption of treatment guidelines, and advocacy with Country Coordinating Mechanisms for scale up.
  • Monitoring and reporting on UNITAID project implementation: To guarantee impact, UNITAID must ensure products are reaching those they are intended for. Formal grantee reporting processes are one way to do this, but a fuller picture can be obtained if civil society are involved in M&E. CS could gather data on whether UNITAID products are reaching intended recipients, the quality and equity of service delivery, stockouts, leakage along the supply chain, and appropriateness of products for communities.
  • UNITAID IP strategy development and implementation: Addressing IP barriers is crucial to improving access to life saving commodities. We are continuing to closely monitor UNITAID’s work on this and the implementation of a recent call for proposals under this area of work. We are also encouraging the organisation to think about future opportunities for investment.
  • Funding: UNITAID has no current funding mechanism specifically for CS other than support for the NGO and Communities delegations. UNITAID should investigate options for funding civil society including: sub grants within existing grants, dual track funding, direct funding to a coordinating CSO and coordination with other funders.
  • Governance: the UNITAID Board has two seats for civil society, one for NGOs working to end HIV/AIDS, TB, Malaria and HCV and one for Communities living with or affected by HIV/AIDS, TB, Malaria, and HCV.

The UNITAID Board

The Executive Board is the decision-making body of UNITAID. The Executive Board makes all decisions relating to UNITAID (except for those delegated to the Secretariat). For example, the Executive Board determines UNITAIDs objectives, scope and work plan and approves all partnership arrangements with other organizations and institutions. It also monitors UNITAIDs progress, approves UNITAID budgets and financial commitments and participates in the performance review of the Executive Secretary. The Board generally takes its decisions by consensus.

The Executive Board consists of 12 Members:

  • One representative nominated from each of the five founding countries (Brazil, Chile, France, Norway and the United Kingdom), and Spain;
  • One representative of African countries designated by the African Union;
  • One representative of Asian countries;
  • One representative from NGOs working on HIV/AIDS, TB, Malaria and HCV
  • One representative from Communities living with or affected by HIV/AIDS, TB, Malaria and HCV
  • One representative of the constituency of foundations; and
  • One representative of the World Health Organization.

The Executive Board is chaired by Celso Amorim, Former Minister of Foreign Affairs for Brazil and an architect of the 2001 Doha deceleration on access to TRIPS flexibilities.

The UNITAID board has included two designated seats for civil society since it was created in 2006. One is for communities living with or affected by HIV/AIDS, TB and malaria and one is for NGOs working on the global response to the three diseases.

The NGO and communities board members are supported by their respective delegations. Anyone living with or affected by HIV/AIDS, TB or malaria can join the Communities delegation and anyone working for an NGO on the global response to the three diseases can join the NGO delegation.

Delegation members have regular opportunities to input into UNITAID decision making processes and will be involved in lobbying governments and expanding civil society’s work on the three diseases.